| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
See Remarks
1 company
Atillasoy Ercem is a See Remarks at Kalaris Therapeutics, Inc.. Recent SEC Form 4 filings include 1 buy and 8 sells.
Estimated insider holdings value: $578K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 20, 2022 | KLRS Kalaris Therapeutics, Inc. | See Remarks | Sell | 2,095 | $8.72 | $18,272.40 | -0.8% | -38.3% | -82.4% | |
| Jul 21, 2022 | KLRS Kalaris Therapeutics, Inc. | See Remarks | Sell | 1,533 | $5.38 | $8,245.09 | -1.1% | +78.8% | -33.7% | |
| Jul 20, 2022 | KLRS Kalaris Therapeutics, Inc. | See Remarks | Sell | 563 | $5.21 | $2,935.76 | -0.4% | +87.2% | -37.9% | |
| Apr 21, 2022 | KLRS Kalaris Therapeutics, Inc. | See Remarks | Sell | 2,040 | $6.04 | $12,328.60 | -0.8% | -1.7% | -29.0% | |
| Jan 25, 2022 | KLRS Kalaris Therapeutics, Inc. | See Remarks | Sell | 4,639 | $8.24 | $38,247.63 | -4.4% | -40.1% | -32.3% | |
| Oct 21, 2021 | KLRS Kalaris Therapeutics, Inc. | See Remarks | Sell | 1,514 | $24.23 | $36,690.43 | -1.4% | -64.7% | -65.5% | |
| Aug 3, 2020 | KLRS Kalaris Therapeutics, Inc. | See Remarks | Buy | 3,500 | $17.00 | $59,500.00 | +4.7% | - | - |